Acid-responsive engineered bacteria with aberrant In-Situ anti-PD-1 expression for post-ablation immunotherapy of hepatocellular carcinoma

Authors:

Abstract
No abstract available
Funding Information
  • Basic and Applied Basic Research Foundation of Guangdong Province (2020A1515110654)
  • National Natural Science Foundation of China (82202271)
  • National Natural Science Foundation of China (82001930)
  • National Natural Science Foundation of China (82172043)
  • National Natural Science Foundation of China (82202273)
  • National Natural Science Foundation of China (82001929)

This publication has 33 references indexed in Scilit: